» Articles » PMID: 10411917

Thirty-seven Candidate Genes for Polycystic Ovary Syndrome: Strongest Evidence for Linkage is with Follistatin

Overview
Specialty Science
Date 1999 Jul 21
PMID 10411917
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder of women, characterized by hyperandrogenism and chronic anovulation. It is a leading cause of female infertility and is associated with polycystic ovaries, hirsutism, obesity, and insulin resistance. We tested a carefully chosen collection of 37 candidate genes for linkage and association with PCOS or hyperandrogenemia in data from 150 families. The strongest evidence for linkage was with the follistatin gene, for which affected sisters showed increased identity by descent (72%; chi(2) = 12.97; nominal P = 3.2 x 10(-4)). After correction for multiple testing (33 tests), the follistatin findings were still highly significant (P(c) = 0.01). Although the linkage results for CYP11A were also nominally significant (P = 0.02), they were no longer significant after correction. In 11 candidate gene regions, at least one allele showed nominally significant evidence for population association with PCOS in the transmission/disequilibrium test (chi(2) >/= 3.84; nominal P < 0.05). The strongest effect in the transmission/disequilibrium test was observed in the INSR region (D19S884; allele 5; chi(2) = 8.53) but was not significant after correction. Our study shows how a systematic screen of candidate genes can provide strong evidence for genetic linkage in complex diseases and can identify those genes that should have high (or low) priority for further study.

Citing Articles

Shared Pathophysiological Mechanisms and Genetic Factors in Early Menarche and Polycystic Ovary Syndrome.

Tinano F, Machado I, Latronico A, Gomes L J Neurosci. 2025; 45(11).

PMID: 40074331 PMC: 11905354. DOI: 10.1523/JNEUROSCI.1681-24.2024.


The Pathophysiological Mechanism and Clinical Treatment of Polycystic Ovary Syndrome: A Molecular and Cellular Review of the Literature.

Chang K, Chen J, Chen K Int J Mol Sci. 2024; 25(16).

PMID: 39201722 PMC: 11354688. DOI: 10.3390/ijms25169037.


Single-cell transcriptomic profiling unveils insights into ovarian fibrosis in obese mice.

Xiao B, Dai Z, Li Z, Xu D, Yin H, Yang F Biol Direct. 2024; 19(1):52.

PMID: 38956667 PMC: 11218254. DOI: 10.1186/s13062-024-00496-9.


Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.

Barnes D, Tyrer J, Dennis J, Leslie G, Bolla M, Lush M medRxiv. 2024; .

PMID: 38496424 PMC: 10942532. DOI: 10.1101/2024.02.29.24303243.


The polycystic ovary syndrome: the first 150 years of study.

Adashi E, Cibula D, Peterson M, Azziz R F S Rep. 2023; 4(1):2-18.

PMID: 36959968 PMC: 10028479. DOI: 10.1016/j.xfre.2022.12.002.


References
1.
Suarez B, Hodge S . A simple method to detect linkage for rare recessive diseases: an application to juvenile diabetes. Clin Genet. 1979; 15(2):126-36. DOI: 10.1111/j.1399-0004.1979.tb01751.x. View

2.
Jahanfar S, Eden J, Warren P, Seppala M, Nguyen T . A twin study of polycystic ovary syndrome. Fertil Steril. 1995; 63(3):478-86. View

3.
GIVENS J . Familial polycystic ovarian disease. Endocrinol Metab Clin North Am. 1988; 17(4):771-83. View

4.
ORahilly S, Choi W, Patel P, Turner R, Flier J, Moller D . Detection of mutations in insulin-receptor gene in NIDDM patients by analysis of single-stranded conformation polymorphisms. Diabetes. 1991; 40(6):777-82. DOI: 10.2337/diab.40.6.777. View

5.
Kiddy D, Bush A, Short F, Anyaoku V, Reed M, Franks S . Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 1992; 36(1):105-11. DOI: 10.1111/j.1365-2265.1992.tb02909.x. View